TFS CAPITAL LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 105 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$755,000
-18.6%
46,859
-39.4%
0.14%
+3.7%
Q1 2016$928,000
-75.0%
77,360
-70.3%
0.13%
-66.4%
Q4 2015$3,706,000
-17.2%
260,426
-32.0%
0.40%
-7.6%
Q3 2015$4,478,000
-19.3%
383,030
+21.4%
0.43%
-20.3%
Q2 2015$5,546,000
+20.1%
315,495
+2.2%
0.54%
+19.9%
Q1 2015$4,617,000
+2750.0%
308,624
+2106.5%
0.45%
+2913.3%
Q4 2014$162,000
-27.0%
13,987
-26.7%
0.02%
-21.1%
Q3 2014$222,00019,0870.02%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders